Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 3/20 | 0.55 |
| ▸ | TUBB | P07437 | 3/20 | 0.55 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.55 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.55 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.55 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.55 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.55 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.55 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.55 |
| ▸ | TUBA3E | Q6PEY2 | 3/20 | 0.55 |
| ▸ | TUBA1A | Q71U36 | 3/20 | 0.55 |
| ▸ | TUBA1C | Q9BQE3 | 3/20 | 0.55 |
| ▸ | TUBB6 | Q9BUF5 | 3/20 | 0.55 |
| ▸ | TUBB2B | Q9BVA1 | 3/20 | 0.55 |
| ▸ | TUBB1 | Q9H4B7 | 3/20 | 0.55 |
| ▸ | TPMT | P51580 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28275397 | 1.00 | TUBB4A (0.55) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL28788059 | 0.91 | TUBB4A (0.47) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL11564666 | 0.91 | TUBB4A (0.47) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29728505 | 0.91 | TUBB4A (0.47) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29728503 | 0.88 | TUBB4A (0.45) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL28788063 | 0.88 | TUBB4A (0.45) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL27189692 | 0.88 | ALDH1A1 (0.68) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL14218378 | 0.88 | TPMT (0.47) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL30822595 | 0.88 | ALDH1A1 (0.68) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL7122998 | 0.87 | BPTF (0.53) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552931-B2 | Dihydroxy lactam based polymers, compositions and applications thereof | ISP INVESTMENTS LLC (US) | 2026-02-17 | — | — | US | claimed |
| US-20240400581-A1 | Process for Preparing a Macrocyclic Compound Having ENT1 Inhibiting Activity | iTeos Belgium SA (BE) | 2024-12-05 | — | — | US | claimed |
| CN-115894386-B | 1,2, 3-Triazole compound with IDO1 inhibition function and preparation method thereof | 南开大学 | 2024-10-25 | — | — | CN | claimed |
| CN-118772131-A | Biaryl compound and preparation method and application thereof | 河南大学 | 2024-10-15 | — | — | CN | claimed |
| CN-118221833-A | Functionalized nano-cellulose, preparation method thereof and automobile part | 中国第一汽车股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-113999126-B | Preparation method of trimebutine | 浙江东亚药业股份有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-117737998-A | Anti-aging polyester filament yarn base cloth | 常德天鼎丰非织造布有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-116693524-B | Preparation method of bustle | 长春迈灵生物工程有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-116693524-A | Preparation method of bustle | 长春迈灵生物工程有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-115894386-A | 1,2,3-triazole compound with IDO1 inhibition function and preparation method thereof | 南开大学 | 2023-04-04 | — | — | CN | claimed |
| EP-2231151-A2 | ANTIFOLATE COMPOUNDS FOR THE TREATMENT OF MELANOMA | Universidad de Murcia (ES) | 2010-09-29 | — | — | EP | claimed |
| WO-2009081275-A2 | ANTIFOLATE COMPOUNDS FOR THE TREATMENT OF MELANOMA | UNIVERSIDAD DE MURCIA (ES) | 2009-07-02 | — | — | WO | claimed |
| US-6214990-B1 | 2,9-BIS(4-METHOXYBENZOYLOXY),3,10-DIMETHOXY,6,13-DICHLORO -PHENODIOXAZINE, FOR EXAMPLE; DYE HAS NARROW LIGHT ABORPTION BAND AND HIGH DICHROIC RATIO | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-04-10 | — | — | US | claimed |
| EP-0993436-A1 | (S) 2-METHYLAMINO-2-PHENYL-$i(n)-BUTYL 3,4,5-TRIMETHOXYBENZOATE, ITS APPLICATION TO THE TREATMENT OF CHRONIC PAIN | PARKE-DAVIS (FR) | 2000-04-19 | — | — | EP | claimed |
| WO-1999001417-A1 | (S) 2-METHYLAMINO-2-PHENYL-n-BUTYL 3,4,5-TRIMETHOXYBENZOATE, ITS APPLICATION TO THE TREATMENT OF CHRONIC PAIN | PARKE-DAVIS (FR) | 1999-01-14 | — | — | WO | claimed |
| US-4923870-A | 2-Carbonyl substituted N,N'-di-(trimethoxygenzoyl)piperazines, process for preparing the same and therapeutical compounds containing them | Societe de Conseils de Reserches et d'Applications Scientifiques (FR) | 1990-05-08 | — | — | US | claimed |
| US-4507499-A | N-(4-Hydroxybenzyl)-3,4,5-trimethoxybenzamide and method for producing trimethobenzamide chlorohydrate | FRANCIS S.P.A. (IT) | 1985-03-26 | — | — | US | claimed |
| EP-0088147-A1 | A new compound with analgesic, antiinflammatory and antipyretic activity, process for the preparation thereof and pharmaceutical compositions therefrom | AUSONIA FARMACEUTICI S.r.l. (IT) | 1983-09-14 | — | — | EP | claimed |
| EP-0005232-B1 | ISOQUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-08-25 | — | — | EP | claimed |
| US-4104278-A | Process for the production of compounds with antiphlogistic activity | TROPONWERKE DINKLAGE & CO. (DE) | 1978-08-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552931-B2 | Dihydroxy lactam based polymers, compositions and applications thereof | PARG, GNE, PGLS | TUBB4A 1614/4885TUBB 862/4885TUBA3C 1759/4885 |
| US-20240400581-A1 | Process for Preparing a Macrocyclic Compound Having ENT1 Inhibiting Activity | ENTPD5, ENTPD1, ENTPD8 | TUBB4A 4273/4885TUBB 4379/4885TUBA3C 4402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.